1. Home
  2. BNTC vs MIN Comparison

BNTC vs MIN Comparison

Compare BNTC & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • MIN
  • Stock Information
  • Founded
  • BNTC 1995
  • MIN 1988
  • Country
  • BNTC United States
  • MIN United States
  • Employees
  • BNTC N/A
  • MIN N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • MIN Trusts Except Educational Religious and Charitable
  • Sector
  • BNTC Health Care
  • MIN Finance
  • Exchange
  • BNTC Nasdaq
  • MIN Nasdaq
  • Market Cap
  • BNTC 365.1M
  • MIN 303.8M
  • IPO Year
  • BNTC N/A
  • MIN N/A
  • Fundamental
  • Price
  • BNTC $16.61
  • MIN $2.62
  • Analyst Decision
  • BNTC Strong Buy
  • MIN
  • Analyst Count
  • BNTC 5
  • MIN 0
  • Target Price
  • BNTC $24.80
  • MIN N/A
  • AVG Volume (30 Days)
  • BNTC 63.1K
  • MIN 331.0K
  • Earning Date
  • BNTC 11-13-2025
  • MIN 01-01-0001
  • Dividend Yield
  • BNTC N/A
  • MIN 7.31%
  • EPS Growth
  • BNTC N/A
  • MIN N/A
  • EPS
  • BNTC N/A
  • MIN 0.08
  • Revenue
  • BNTC N/A
  • MIN N/A
  • Revenue This Year
  • BNTC N/A
  • MIN N/A
  • Revenue Next Year
  • BNTC N/A
  • MIN N/A
  • P/E Ratio
  • BNTC N/A
  • MIN $33.38
  • Revenue Growth
  • BNTC N/A
  • MIN N/A
  • 52 Week Low
  • BNTC $9.10
  • MIN $2.52
  • 52 Week High
  • BNTC $17.15
  • MIN $2.88
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 72.99
  • MIN 35.05
  • Support Level
  • BNTC $15.18
  • MIN $2.63
  • Resistance Level
  • BNTC $16.62
  • MIN $2.68
  • Average True Range (ATR)
  • BNTC 0.69
  • MIN 0.02
  • MACD
  • BNTC 0.13
  • MIN -0.00
  • Stochastic Oscillator
  • BNTC 99.67
  • MIN 18.75

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About MIN MFS Intermediate Income Trust

MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.

Share on Social Networks: